מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
Cobicistat; Tenofovir disoproxil fumarate; Emtricitabine; Elvitegravir
Gilead Sciences Pty Ltd
Medicine Registered
CONSUMER MEDICINE INFORMATION STRIBILD TM TABLETS (300 MG TENOFOVIR DISOPROXIL FUMARATE / 200 MG EMTRICITABINE/ 150 MG OF ELVITEGRAVIR / 150 MG OF COBICISTAT.) WHAT IS IN THIS LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. This leaflet answers some of the common questions about STRIBILD tablets. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist about your medical condition or treatment. If you have further questions, please ask your doctor or your pharmacist. Keep this leaflet with your STRIBILD medicine. You may need to read it again. This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours. WHAT IS STRIBILD? STRIBILD consists of four medicines VIREAD ® (tenofovir disoproxil fumarate, also called tenofovir DF), EMTRIVA ® (emtricitabine or FTC), elvitegravir and cobicistat, combined in one tablet to help control Human Immunodeficiency Virus (HIV) infection. VIREAD and EMTRIVA belong to a group of antiviral medicines known as nucleoside and nucleotide reverse transcriptase inhibitors (NRTI). Elvitegravir belongs to a new class of antiviral medicines known as integrase inhibitors. Cobicistat is a “booster”, to help increase the levels of elvitegravir. Tenofovir DF and emtricitabine are components of TRUVADA ® and ATRIPLA ® tablets. STRIBILD is used to treat HIV infection. STRIBILD is for people who have NEVER taken HIV medicines before, or who do not have a resistant HIV virus to STRIBILD. STRIBILD is for adults. STRIBILD has not been studied in children under the age of 18 or adults over the age of 65. HIV infection destroys CD4 T cells, which are important to the immune system. The immu קרא את המסמך השלם
PRODUCT INFORMATION STRIBILD™ (TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE/ELVITEGRAVIR/COBICISTAT) TABLETS NAME OF THE MEDICINE STRIBILD (tenofovir disoproxil fumarate/emtricitabine/elvitegravir/cobicistat) tablets. The active substances in STRIBILD tablets are tenofovir disoproxil fumarate (tenofovir DF), emtricitabine, elvitegravir and cobicistat. VIREAD ® is the brand name for tenofovir DF, which is converted _in vivo_ to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate. EMTRIVA ® is the brand name for emtricitabine (FTC), a synthetic nucleoside analog of cytidine. Tenofovir DF and emtricitabine exhibit activity against HIV-1 reverse transcriptase (RT). Tenofovir DF and emtricitabine are the components of TRUVADA ® . Elvitegravir is a human immunodeficiency virus-1 (HIV-1) integrase strand transfer inhibitor. Cobicistat is a mechanism-based inhibitor of cytochrome P-450 (CYP) enzymes of the CYP3A family. DESCRIPTION _TENOFOVIR DISOPROXIL FUMARATE_: Tenofovir DF is a fumaric acid salt of the _bis_- isopropoxycarbonyloxymethyl ester derivative of tenofovir. The chemical name of tenofovir DF is 9-[(_R_)-2 [[bis[[(isopropoxycarbonyl)oxy] methoxy]phosphinyl]methoxy]propyl]adenine fumarate (1:1). It has a molecular formula of C 19 H 30 N 5 O 10 P • C 4 H 4 O 4 and a molecular weight of 635.52. It has the following structural formula: N N N N O P O O O O O O NH 2 CH 3 CO 2 H H HO 2 C H O O O CAS registry number: 202138-50-9 Tenofovir DF is a white to off-white crystalline powder with a solubility of 13.4 mg/mL in water at 25 °C. The partition coefficient (_log p_) for tenofovir disoproxil is 1.25 and the pKa is 3.75. _ _ _EMTRICITABINE:_ The chemical name of emtricitabine is 5-fluoro-1-(2_R_,5_S_)-[2-(hydroxymethyl)- 1,3-oxathiolan-5-yl]cytosine. Emtricitabine is the (-) enantiomer of a thio analog of cytidine, which differs from other קרא את המסמך השלם